Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Siderius

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|March 29, 2025
Pharmacological characterization of a clinical candidate, TG-0054, a small molecule inverse agonist targeting CXCR4Kylie S Pan, Ziming Wang, Cy Pfeil, et al.
Biochemical Pharmacology|August 4, 2024
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonismStephanie M Anbuhl, Xavier Dervillez, Saskia Neubacher, et al.
Molecular Cell|June 26, 2012
Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machineWanping Xu, Mehdi Mollapour, Chrisostomos Prodromou, et al.
Science Signaling|August 15, 2023
A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P<sub>1</sub> signaling axisNick D Bergkamp, Jeffrey R van Senten, Hendrik J Brink, et al.
Future Medicinal Chemistry|August 3, 2019
Discovery of novel <i>Schistosoma mansoni</i> PDE4A inhibitors as potential agents against schistosomiasisVíctor Sebastián-Pérez, Susanne Schroeder, Jane C Munday, et al.
Iscience|August 14, 2023
Exosomal release of the virus-encoded chemokine receptor US28 contributes to chemokine scavengingMaarten P Bebelman, Irfan M Setiawan, Nick D Bergkamp, et al.
Journal of Medicinal Chemistry|July 20, 2023
Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo EfficacyYang Zheng, Magali van den Kerkhof, Tiffany van der Meer, et al.
Cell Reports Methods|April 14, 2023
NanoB<sup>2</sup> to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRETJelle van den Bor, Nick D Bergkamp, Stephanie M Anbuhl, et al.
ACS Chemical Biology|October 18, 2022
Fusicoccin-A Targets Cancerous Inhibitor of Protein Phosphatase 2A by Stabilizing a C-Terminal Interaction with 14-3-3Hendrik J Brink, Jeffrey R van Senten, Ingrid J De Vries-van Leeuwen, et al.
Nature Communications|July 17, 2021
Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodiesTimo W M De Groof, Nick D Bergkamp, Raimond Heukers, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|March 29, 2025
Pharmacological characterization of a clinical candidate, TG-0054, a small molecule inverse agonist targeting CXCR4Kylie S Pan, Ziming Wang, Cy Pfeil, et al.
Biochemical Pharmacology|August 4, 2024
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonismStephanie M Anbuhl, Xavier Dervillez, Saskia Neubacher, et al.
Molecular Cell|June 26, 2012
Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machineWanping Xu, Mehdi Mollapour, Chrisostomos Prodromou, et al.
Science Signaling|August 15, 2023
A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P<sub>1</sub> signaling axisNick D Bergkamp, Jeffrey R van Senten, Hendrik J Brink, et al.
Future Medicinal Chemistry|August 3, 2019
Discovery of novel <i>Schistosoma mansoni</i> PDE4A inhibitors as potential agents against schistosomiasisVíctor Sebastián-Pérez, Susanne Schroeder, Jane C Munday, et al.
Iscience|August 14, 2023
Exosomal release of the virus-encoded chemokine receptor US28 contributes to chemokine scavengingMaarten P Bebelman, Irfan M Setiawan, Nick D Bergkamp, et al.
Journal of Medicinal Chemistry|July 20, 2023
Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo EfficacyYang Zheng, Magali van den Kerkhof, Tiffany van der Meer, et al.
Cell Reports Methods|April 14, 2023
NanoB<sup>2</sup> to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRETJelle van den Bor, Nick D Bergkamp, Stephanie M Anbuhl, et al.
ACS Chemical Biology|October 18, 2022
Fusicoccin-A Targets Cancerous Inhibitor of Protein Phosphatase 2A by Stabilizing a C-Terminal Interaction with 14-3-3Hendrik J Brink, Jeffrey R van Senten, Ingrid J De Vries-van Leeuwen, et al.
Nature Communications|July 17, 2021
Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodiesTimo W M De Groof, Nick D Bergkamp, Raimond Heukers, et al.
Pageof 6